Age as predictor in patients with cutaneous melanoma submitted to sentinel lymph node biopsy

C. Caracò, U. Marone, G. Botti, E. Celentano, S. Lastoria, N. Mozzillo

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Aims: To analyse the age as prognostic factor exploring the melanoma database at the National Cancer Institute in Naples. Methods: Three hundred and ninety-nine patients with cutaneous melanoma were treated with sentinel lymph node biopsy from 1996 to 2003 at the National Cancer Institute of Naples. The results were analysed with particular attention to the overall survival among patients younger or older than 50 years of age. Results: No differences were recorded between the younger and older group in terms of the identification rate and incidence of metastases. The analyses of disease-free survival and overall survival showed a significantly more favourable outcome in younger patients. The 5-year overall survival and the 5-year disease free survival were 81.8% vs. 68.0% and 76.3% vs. 59.1% for the younger and older group, respectively. Conclusions: The results suggest that in the management of cutaneous melanoma, age might be considered as prognostic factor both for disease free survival and overall survival.

Original languageEnglish
Pages (from-to)970-973
Number of pages4
JournalEuropean Journal of Surgical Oncology
Volume32
Issue number9
DOIs
Publication statusPublished - Nov 2006

Fingerprint

Sentinel Lymph Node Biopsy
Melanoma
Disease-Free Survival
Skin
Survival
National Cancer Institute (U.S.)
Databases
Neoplasm Metastasis
Incidence

Keywords

  • Cutaneouhs melanoma
  • Lymph node metastasis
  • Prognostic factors
  • Sentinel biopsy

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Age as predictor in patients with cutaneous melanoma submitted to sentinel lymph node biopsy. / Caracò, C.; Marone, U.; Botti, G.; Celentano, E.; Lastoria, S.; Mozzillo, N.

In: European Journal of Surgical Oncology, Vol. 32, No. 9, 11.2006, p. 970-973.

Research output: Contribution to journalArticle

@article{50200e73cfd042ac878af2eadf86c41b,
title = "Age as predictor in patients with cutaneous melanoma submitted to sentinel lymph node biopsy",
abstract = "Aims: To analyse the age as prognostic factor exploring the melanoma database at the National Cancer Institute in Naples. Methods: Three hundred and ninety-nine patients with cutaneous melanoma were treated with sentinel lymph node biopsy from 1996 to 2003 at the National Cancer Institute of Naples. The results were analysed with particular attention to the overall survival among patients younger or older than 50 years of age. Results: No differences were recorded between the younger and older group in terms of the identification rate and incidence of metastases. The analyses of disease-free survival and overall survival showed a significantly more favourable outcome in younger patients. The 5-year overall survival and the 5-year disease free survival were 81.8{\%} vs. 68.0{\%} and 76.3{\%} vs. 59.1{\%} for the younger and older group, respectively. Conclusions: The results suggest that in the management of cutaneous melanoma, age might be considered as prognostic factor both for disease free survival and overall survival.",
keywords = "Cutaneouhs melanoma, Lymph node metastasis, Prognostic factors, Sentinel biopsy",
author = "C. Carac{\`o} and U. Marone and G. Botti and E. Celentano and S. Lastoria and N. Mozzillo",
year = "2006",
month = "11",
doi = "10.1016/j.ejso.2006.07.007",
language = "English",
volume = "32",
pages = "970--973",
journal = "European Journal of Surgical Oncology",
issn = "0748-7983",
publisher = "W.B. Saunders Ltd",
number = "9",

}

TY - JOUR

T1 - Age as predictor in patients with cutaneous melanoma submitted to sentinel lymph node biopsy

AU - Caracò, C.

AU - Marone, U.

AU - Botti, G.

AU - Celentano, E.

AU - Lastoria, S.

AU - Mozzillo, N.

PY - 2006/11

Y1 - 2006/11

N2 - Aims: To analyse the age as prognostic factor exploring the melanoma database at the National Cancer Institute in Naples. Methods: Three hundred and ninety-nine patients with cutaneous melanoma were treated with sentinel lymph node biopsy from 1996 to 2003 at the National Cancer Institute of Naples. The results were analysed with particular attention to the overall survival among patients younger or older than 50 years of age. Results: No differences were recorded between the younger and older group in terms of the identification rate and incidence of metastases. The analyses of disease-free survival and overall survival showed a significantly more favourable outcome in younger patients. The 5-year overall survival and the 5-year disease free survival were 81.8% vs. 68.0% and 76.3% vs. 59.1% for the younger and older group, respectively. Conclusions: The results suggest that in the management of cutaneous melanoma, age might be considered as prognostic factor both for disease free survival and overall survival.

AB - Aims: To analyse the age as prognostic factor exploring the melanoma database at the National Cancer Institute in Naples. Methods: Three hundred and ninety-nine patients with cutaneous melanoma were treated with sentinel lymph node biopsy from 1996 to 2003 at the National Cancer Institute of Naples. The results were analysed with particular attention to the overall survival among patients younger or older than 50 years of age. Results: No differences were recorded between the younger and older group in terms of the identification rate and incidence of metastases. The analyses of disease-free survival and overall survival showed a significantly more favourable outcome in younger patients. The 5-year overall survival and the 5-year disease free survival were 81.8% vs. 68.0% and 76.3% vs. 59.1% for the younger and older group, respectively. Conclusions: The results suggest that in the management of cutaneous melanoma, age might be considered as prognostic factor both for disease free survival and overall survival.

KW - Cutaneouhs melanoma

KW - Lymph node metastasis

KW - Prognostic factors

KW - Sentinel biopsy

UR - http://www.scopus.com/inward/record.url?scp=33750296561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750296561&partnerID=8YFLogxK

U2 - 10.1016/j.ejso.2006.07.007

DO - 10.1016/j.ejso.2006.07.007

M3 - Article

C2 - 16996239

AN - SCOPUS:33750296561

VL - 32

SP - 970

EP - 973

JO - European Journal of Surgical Oncology

JF - European Journal of Surgical Oncology

SN - 0748-7983

IS - 9

ER -